Participant and Recruitment Information
šParticipant Information
šEnrol in the Study
šFAQs
For enquires related to this study please contact sydneymdstudy@gmail.com
To participate in this study, you must be planning to microdose during the next three months, be aged between 18 and 70 years old, be proficient in English, and be able to attend Macquarie University in Sydney on two assessment days (each visit will last about 2 hours). To take part, you must not have a history or current diagnosis of primary psychotic disorder, bipolar disorder, dissociative disorder, or substance use disorder. You must not have a family history of schizophrenia or psychosis. Additionally, you must not be pregnant or planning to be pregnant during the study, have uncontrolled hypertension or other cardiac conditions.
The MEG scan takes place in a small room, and participants will be required to lie in a confined scanner for up to 45 minutes.
You are free to discontinue the study immediately and at any time, without providing a reason.
You will be making a valuable contribution to the science of microdosing! Also, we can offer $100 for participation in this study ($50 per lab visit). We can additionally reimburse you for travel costs incurred travelling to Macquarie University (from within Sydney only).
Your privacy will be protected and we will only store identifiable information in order to schedule lab visits. All information that you provide will be de-identified, and results of this study will only be reported as group data.
If you would like to participate, or to find out more, please enrol below.
Finally, if you know of anyone who may be interested in this study, please pass this information on.
Thank you for your support of this research.
Dr Vince Polito (Department of Cognitive Science, Macquarie University) Phone: +61 2 9850 2966 Email: vince.polito@mq.edu.au
Dr Paul Liknaitzky (School of Psychological Sciences and Dept of Psychiatry, Monash University) Email: Paul.L@monash.edu
If you would like to enrol in the study, you will be asked to complete a brief questionnaire to assess your eligibility.
This study is open to people aged 18-70 who are based in Sydney Australia. You must already have access to microdoses of psilocybin in order to take part in the study. Unfortunately, we cannot enrol participants with a history of some mental illnesses. More information is provided above.
No. We do not provide any substances to participants in this study. This is an observational study, investigating the experiences of people who are already microdosing. There are two reasons for this study design:
Unfortunately we can’t provide any information on sourcing psychedelics. These substances are prohibited in Australia and we do not encourage anyone to start using these substances.
People with a diagnoses of psychotic disorder, bipolar disorder, dissociative disorder, or substance use disorder canāt take part in the study. Additionally people with a family history of schizophrenia or psychosis cannot take part. While the potential for psychedelics to help treat various mental illnesses is being explored in Australia and internationally, this is not a key focus of the current study. Accordingly, this trial does not provide the clinical support and infrastructure required to safely explore clinical applications, and the scientific aims of this study require participants without mental illness.
Although psychedelics are illegal in Australia we acknowledge that many people use these substances. We don’t encourage this but we would like to understand the effects, potential benefits and possible risks of these practices.
We take participant privacy and security extremely seriously in this study. Here are some of the considerations and steps that we take:
After you complete the initial screening survey, if you are eligible we will contact you within 3 days to schedule your lab visits. If you do not hear from us (or if you have any problems with the screening survey) please write to the email address below.
If you have any additional questions please contact as at sydneymdstudy@gmail.com